Immunome Insider Sold Shares Worth $1,244,331, According to a Recent SEC Filing
Robert Lechleider, Chief Medical Officer, on July 02, 2026, sold 55,000 shares in Immunome (IMNM) for $1,244,331. Following the Form 4 filing with the SEC, Lechleider has control over a total of 15,805 common shares of the company, with 15,805 shares held directly. SEC Filing:
Robert Lechleider, Chief Medical Officer, on July 02, 2026, sold 55,000 shares in Immunome (IMNM) for $1,244,331.
Following the Form 4 filing with the SEC, Lechleider has control over a total of 15,805 common shares of the company, with 15,805 shares held directly.
SEC Filing: